Guardant Health Inc (NASDAQ: GH) kicked off on Friday, down -4.45% from the previous trading day, before settling in for the closing price of $45.15. Over the past 52 weeks, GH has traded in a range of $15.81-$50.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 28.17% over the past five years. While this was happening, its average annual earnings per share was recorded 19.03%. With a float of $117.96 million, this company’s outstanding shares have now reached $123.99 million.
Let’s look at the performance matrix of the company that is accounted for 2021 employees. In terms of profitability, gross margin is 60.79%, operating margin of -60.02%, and the pretax margin is -58.87%.
Guardant Health Inc (GH) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.42%, while institutional ownership is 96.26%. The most recent insider transaction that took place on Mar 19 ’25, was worth 5,069. In this transaction Director of this company sold 116 shares at a rate of $43.70, taking the stock ownership to the 3,211 shares. Before that another transaction happened on Mar 19 ’25, when Company’s Director proposed sale 116 for $43.70, making the entire transaction worth $5,069.
Guardant Health Inc (GH) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.52% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Take a look at Guardant Health Inc’s (GH) current performance indicators. Last quarter, stock had a quick ratio of 4.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.56, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.46 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Guardant Health Inc (NASDAQ: GH) saw its 5-day average volume 1.32 million, a negative change from its year-to-date volume of 2.39 million. As of the previous 9 days, the stock’s Stochastic %D was 55.99%. Additionally, its Average True Range was 2.83.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 73.03%, which indicates a significant increase from 59.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.72% in the past 14 days, which was higher than the 72.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.44, while its 200-day Moving Average is $32.74. Nevertheless, the first resistance level for the watch stands at $44.96 in the near term. At $46.79, the stock is likely to face the second major resistance level. The third major resistance level sits at $47.92. If the price goes on to break the first support level at $42.00, it is likely to go to the next support level at $40.87. Assuming the price breaks the second support level, the third support level stands at $39.04.
Guardant Health Inc (NASDAQ: GH) Key Stats
The company with the Market Capitalisation of 5.32 billion has total of 123,421K Shares Outstanding. Its annual sales at the moment are 739,020 K in contrast with the sum of -436,370 K annual income. Company’s last quarter sales were recorded 201,810 K and last quarter income was -111,010 K.
